Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid structure

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid 

structure
  • CAS No:

    20170-32-5

  • Formula:

    C17H26O3

  • Chemical Name:

    3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid

  • Synonyms:

    3,5-Di-tert-butyl-4-hydroxybenzenepropionic acid;Fenozan acid;3,5-Di-tert-butyl-4-hydroxyphenylpropionic acid, 98%, 98%;3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoic acid (en);3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid 98%;3,5-di-tert-butyl-4-hydroxyphenylpropionic acid (3,5-DTBHA);Dibutylhydroxyphenylpropionicacid;3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionsure

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid Basic Attributes

278.39

278.39

243-556-1

X6G09G700F

TSCA listed

DTXSID2066561

White to Off-White

2918290090

Characteristics

57.5

4.7

1.049±0.06 g/cm3(Predicted)

172-174°C

364.3±37.0 °C(Predicted)

188.3ºC

1.52

Slightly soluble in water.

4.79±0.10(Predicted)

Sealed in dry,Room Temperature

Safety Information

IRRITANT

36/37/38

26-36/37/39

P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501

36/37/38

|Warning|H302 (78.79%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 33 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)|Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)

4-hydroxy-3,5-di-tert-butylphenylpropionic acid

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid Use and Manufacturing

Methods of Manufacturing

In a nitrogen atmosphere, 117 g (0.4 mol) of methyl β- (3, 5-di-tert-butyl-4-hydroxyphenyl) propionateAnd anhydrous methanol 126.6g added to the reactor, heated to boiling, 120 mL of a 30percent by weight NaOH aqueous solution was added and kept for 2 h, then 80 mL of a 10 wtpercent HCl solution was added, stirred and cooled to room temperature, filtered, washed with deionized water until neutral, The filter cake was dried at 110 ° C for 4 h to give 115 g of white solid A1.

Uses

It is employed as an active pharmaceutical intermediate.

Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-: ACTIVE

Computed Properties

Molecular Weight:278.4
XLogP3:4.7
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:5
Exact Mass:278.18819469
Monoisotopic Mass:278.18819469
Topological Polar Surface Area:57.5
Heavy Atom Count:20
Complexity:311
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.